Delivery Order SPE2DB24D8002-SPE2DB25FJNML
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product STELARA 90 MG/ML SYRINGE. The contract has a firm fixed price ceiling value of $9,397.47 and a period of performance extending until February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of STELARA 90 MG/ML syringes. The contract has a ceiling value of $12,117.01 and a period of performance extending through November 13, 2024. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables the company to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of STELARA 90 MG/ML SYRINGEML. The contract, valued at $8,085.39, has an ultimate completion date of February 18, 2025. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. The IDC allows the company...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $19,196.40, is for the delivery of STELARA 90 MG/ML SYRINGEML medical supplies. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is under the DLA Troop Support...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,866.34 firm-fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on September 22, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,445.88, is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 18, 2025. The contract is a delivery order issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a total potential value of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $33,222.66 and a period of performance through May 16, 2024. The award does not utilize a set-aside designation. Dakota Drug, Inc. is an experienced prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Stelara 90 mg/mL syringes. The total ceiling value of the award is $13,515.40, with a firm fixed price pricing type and an ultimate completion date of December 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at...